Gut Health

Antibiotics, probiotics and anti-virulence: balancing efficacy and evolution

38 views
July 02, 2019 alternate states, antibiotics, anti-resistance, anti-virulence drugs, asymptomatic, carriage states, chronic infections, conditional strategies, cooperative virulence, cystic fibrosis, efficacy, evolution-proof, gallium, IHSIG, microbiomes, models, prediction, resistance, robustness, symptoms, synthetic communities, transitions, treatments
Speaker: Prof Sam BROWN, Georgia Institute of Technology, USA

Drug resistance is an important issue. What about evolutionary robustness in relation of treatment efficacy? Focusing on anti-virulence and anti-resistance features become more and more critical for the development of future solutions vs traditional anti-microbial strategies. Conditional strategies need to be developed to efficiently fight antimicrobial resistance.


6th international Conference on Poultry Intestinal Health (IHSIG)
Add a comment...
Post as (log out)